NHF’s QMS is ISO 9001:2015 Certified

Government of Jamaica

NHF Adds New Drugs for Diabetes and Hypertension

NHF Adds New Drugs for Diabetes and HypertensionNational Health Fund and JADEP cardholders are to benefit from the addition of new drugs and drug combinations for the treatment of diabetes.

New, for the treatment of Diabetes, is Galvus Tablets with the active ingredient Vildagliptin, with a subsidy of $43 per 50mg tablet. There are also combinations of Vildagliptin and Metformin HCl with a subsidy of $42.71 per Galvus Met 50mg/500mg tablet, Galvus Met 50mg/850 mg tablet at $42.88 and Galvus Met 50mg/1000mg tablet at $40.86.

In addition, the combination of Telmisartan and Amlodipine as Twynsta, 80mg/5mg tablet and 80mg/10mg tablet, for the treatment of Hypertension, has been added with a subsidy of $74.82 and $83.67 per tablet respectively.

There is also a decrease in the subsidy for Duotrav Solution 0.0004%/0.5%, with active ingredients Travoprost and Timolol, for the treatment of Glaucoma, now at $1,591 down from $1639.02.

The changes became effective on October 28, 2013.



For further information please contact:

Rosemarie Lee or Jillian Green Tel: 906-1106

National Health Fund © 2024. All Rights Reserved.